1. Startpage

Search

Current filters:


Use filters to refine the search results.

Start a new search
Results 31-38 of 38 (Search time: 0.007 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
ncadherin_distinguishes_intra-20230112135952723.pdf.jpg202213-Jan-2023N-cadherin distinguishes intrahepatic cholangiocarcinoma from liver metastases of ductal adenocarcinoma of the pancreasGerber, Tiemo S.; Goeppert, Benjamin; Hausen, Anne; Witzel, Hagen R.; Bartsch, Fabian; Schindeldecker, Mario; Gröger, Lisa-Katharina; Ridder, Dirk A.; Cahyadi, Oscar; Esposito, Irene; Gaida, Matthias M.; Schirmacher, Peter; Galle, Peter R.; Lang, Hauke; Roth, Wilfried; Straub, Beate K.
biology_and_significance_of_a-20220620120208132.pdf.jpg201920-Jun-2022Biology and significance of alpha-fetoprotein in hepatocellular carcinomaGalle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi; Chan, Stephen L.; Llovet, Josep M.; Qin, Shukui; Schelman, William R.; Chintharlapalli, Sudhakar; Abada, Paolo B.; Sherman, Morris; Zhu, Andrew X.
selective_internal_radiothera-20220914234950293.pdf.jpg20146-Oct-2022Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC) : study protocol for a randomized controlled trialKlöckner, Roman; Ruckes, Christian; Kronfeld, Kai; Wörns, Marcus-Alexander; Weinmann, Arndt; Galle, Peter R.; Lang, Hauke; Otto, Gerd; Eichhorn, Waltraud; Schreckenberger, Mathias; Düber, Christoph; Pitton, Michael B.
cost_evaluation_of_pageb_risk-20220630121855371.pdf.jpg202130-Jun-2022Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis BSprinzl, Martin F.; Feist, Christina; Koch, Sandra; Kremer, Wolfgang Maximilian; Lackner, Karl J.; Weinmann, Arndt; Galle, Peter R.
healthrelated_quality_of_life-20220805150847806.pdf.jpg20219-Aug-2022Health-related quality of life in patients with autoimmune hepatitisMichel, Maurice; Spinelli, Francesca; Grambihler, Annette; Labenz, Christian; Nagel, Michael; Kaps, Leonard; Huber, Yvonne; Galle, Peter R.; Wörns, Marcus-Alexander; Schattenberg, Jörn M.
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
58508.pdf.jpg201817-Oct-2018The immune contexture of hepatocellular carcinoma predicts clinical outcomeFoerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
58506.pdf.jpg201817-Oct-2018Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaMähringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene; Koch, Sandra; Schotten, Sebastian; Pinto dos Santos, Daniel; Pitton, Michael B.; Düber, Christoph; Galle, Peter R.; Klöckner, Roman

Refine search results